MUDDATIDAN OLDIN TUG‘ILGAN CHAQALOQLARDA RETINOPATIYANING KLINIK KECHISHI VA SKRINING TIZIMINI OPTIMALLASHTIRISH.
Keywords:
chaqaloqlar retinopatiyasi, prematuritet, retina angiogenezi, giperoksiya, gipoksiya, VEGF, lazer fotokoagulyatsiya, anti-VEGF terapiya, vitreoretinal jarrohlik, neonatal skrining, kislorod terapiyasi, ko‘rish nuqsonlari, to‘r parda rivojlanishi.Abstract
Ushbu maqolada chaqaloqlar retinopatiyasi (Retinopathy of Prematurity - ROP)ning etiologiyasi, patogenezi, klinik belgilari, xavf omillari va zamonaviy davolash yondashuvlari keng tahlil qilinadi. Muddatidan oldin tug‘ilgan chaqaloqlarda ko‘p uchraydigan ushbu kasallik to‘r pardaning normal qon tomirlari rivojlanishi buzilishi natijasida yuzaga kelib, o‘z vaqtida aniqlanmasa og‘ir ko‘rish nuqsonlariga yoki butunlay ko‘rlikka olib kelishi mumkin. Maqolada ROPning bosqichlari, diagnostika usullari, lazer koagulyatsiyasi, anti-VEGF terapiya va vitreoretinal jarrohlikning samaradorligi ilmiy manbalar asosida o‘rganiladi. Shuningdek, neonatal parvarish, kislorod terapiyasini nazorat qilish va skrining dasturlarining kasallikning oldini olishdagi ahamiyati yoritiladi. Tadqiqot natijalari chaqaloqlar retinopatiyasini erta aniqlash va samarali davolash orqali bolalarda ko‘rish qobiliyatini saqlab qolish imkoniyatlari yuqori ekanligini ko‘rsatadi.
Downloads
References
1. Fierson, W. M. Screening examination of premature infants for retinopathy of prematurity. *Pediatrics*, 2018; 142(6): e20183061.
2. International Committee for the Classification of Retinopathy of Prematurity (ICROP). The International Classification of Retinopathy of Prematurity Revisited. *Archives of Ophthalmology*, 2021; 139(1): 1–9.
3. Good, W. V., Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity randomized trial. *Archives of Ophthalmology*, 2010; 128(6): 663–671.
4. Hellström, A., Smith, L. E., & Dammann, O. Retinopathy of prematurity. *The Lancet*, 2013; 382(9902): 1445–1457.
5. Hartnett, M. E., & Penn, J. S. Mechanisms and management of retinopathy of prematurity. *The New England Journal of Medicine*, 2012; 367(26): 2515–2526.
6. Mintz-Hittner, H. A., Kennedy, K. A., Chuang, A. Z. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. *The New England Journal of Medicine*, 2011; 364(7): 603–615.
7. American Academy of Ophthalmology (AAO). Retinopathy of Prematurity: Preferred Practice Pattern. 2020.
8. World Health Organization. Guidelines on optimal feeding of low birth-weight infants. WHO Publications, 2011.
9. Gilbert, C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. *Early Human Development*, 2008; 84(2): 77–82.
10. VanderVeen, D. K., et al. Prevalence and course of ROP in the neonatal intensive care unit. *Journal of AAPOS*, 2019; 23(4): 209.e1–209.e6.
11. Robin, A. L., & Coats, D. K. Retinopathy of prematurity: advances in management and treatment. *Pediatric Clinics of North America*, 2020; 67(3): 551–566.
12. Shah, P. K., Narendran, V. Practice Guidelines for Screening and Treatment of Retinopathy of Prematurity. *Indian Journal of Ophthalmology*, 2018; 66(7): 920–943.
